FDA bashing is a sport with a long history. Some players have been at it for years. Others are newer to the game. However, regardless of the reasons for participation in this sport, I now believe it should — like fox hunting — be either banned or at least highly controlled, for several reasons.
Filed under: Drug approvals and regulation | Tagged: FDA, oncology drugs, Wall Street Journal | 2 Comments »
Just a few days ago, USA Today (in conjunction with the Kaiser Family Foundation and the Harvard School of Public Health) published a report on public perceptions about prescription drugs and pharmaceutical companies. The full report can be found on the Kaiser Family Foundation web site.
The results of this survey, which encompassed nearly 1700 American [...]
Filed under: Health and drug costs | Tagged: biologics, drug prices, expectations, perceptions, pharmaceuticals, value | Comments Off
